Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Maxcyte (MXCT) FCF Margin (2020 - 2026)

Maxcyte has reported FCF Margin over the past 6 years, most recently at 92.85% for Q4 2025.

  • Quarterly FCF Margin rose 20141.0% to 92.85% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 172.63% through Dec 2025, down 8361.0% year-over-year, with the annual reading at 172.63% for FY2025, 9688.0% down from the prior year.
  • FCF Margin was 92.85% for Q4 2025 at Maxcyte, up from 108.3% in the prior quarter.
  • Over five years, FCF Margin peaked at 92.85% in Q4 2025 and troughed at 189.47% in Q1 2024.
  • The 5-year median for FCF Margin is 94.16% (2022), against an average of 69.24%.
  • Year-over-year, FCF Margin crashed -12088bps in 2024 and then surged 20141bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 50.8% in 2021, then fell by -17bps to 42.26% in 2022, then tumbled by -127bps to 11.46% in 2023, then crashed by -847bps to 108.56% in 2024, then surged by 186bps to 92.85% in 2025.
  • Per Business Quant, the three most recent readings for MXCT's FCF Margin are 92.85% (Q4 2025), 108.3% (Q3 2025), and 109.2% (Q2 2025).